CAMEROON-ENVIRONMENT: Saving a Valuable Medicinal Plant Inter Press Service
click here to return to Inter Press Service main menu
DonateNow


CAMEROON-ENVIRONMENT: Saving a Valuable Medicinal Plant

InterPress News Service (IPS); Friday, 14 February 1997.
Tansa Musa


YAOUNDE, Feb 14 (IPS) -- Korup National Park in south western Cameroon is a scientist's delight. The park spans some 1,259 square kilometres and is a unique primary rain forest which has been described as "a real living museum".

Together with the Nigerian Cross River National Park, Korup, protects a significant area of the West African rain forest zone. Korup, which is estimated to be 60 million years old, has a great diversity of plant and animal life.

Daniel Agoons, conservation officer at the Korup Forest Project, says the forest contains more than 400 varieties of trees and 325 species of birds. There are also 174 species of reptiles and amphibians, as well as 140 fish species.

But the greatest find for Cameroonian scientists in the rain forest was the Ancistrocladus Korupensis, a plant which contains an important alkaloid --Michellamine B -- used in ongoing research for a drug for the Acquired Immune Deficiency Syndrome (AIDS).

According to the Korup Forest Project director Paul Symonds, more than 90 medicinal plants have been discovered in the park, 36 of them new to science.

Ancistrocladus, which grows as a vine, was discovered in the rain forest some six years ago. Because of its importance in AIDS research, scientists in the country have started a programme to conserve the rare plant.

"We fear that using this limited source for anti-AIDS research could eventually lead to extinction of the species. That is why we are attempting to domesticate the plant and increase its production," says Professor Johnson Jato, director of the Bioresources Development and Conservation Programme (BDCP).

Finding ways to propagate the plant is key to its conservation, Jato says. So far, by careful use of high humidity propagators, the BDCP team has succeeded in speeding up the growth of transplanted young plants, and they have been able to germinate and rapidly grow the plant from seeds.

Young plants have been successfully transplanted from the rainforest, domesticated in a nursery and then planted on a farm. They are protected and shaded by palms and watered twice daily.

Cuttings of the plant have also been taken, dipped in a rooting hormone and then planted in a one-to-one mixture of sawdust and sand. The cuttings are placed in humidity propagators where they are constantly examined for rooting.

Scientists continue to test the plants grown outside of the rain forest, the plant's natural environment, for the Michellamine B alkaloid. And so far, the results are "encouraging".

Harvested six months after being transplanted and tested for Michellamine B, both the young and old leaves contained the active alkaloid, with the older ones having a higher content, which suggests that the amount of the compound in the leaves increases with age.

According to Cameroonian scientists, this is an indication that the plant can grow outside of its natural habitat. Early results also show that that the plant can be grown from seeds in a nursery, and that the seeds do not need to be subjected to any special technique to germinate. Out of 150 seeds sown, only four did not germinate.

Scientists say that tests show too that the fallen leaves from the plant also contain Michellamine B and the quantity of the alkaloid in them is slightly higher than in dried fresh leaves.

This further strenghthens evidence that the quantity of the alkaloid increases with the age of the leaves, since the fallen leaves are presumably older.

"It is clear from the study," says Dr C.N. Mbi, a member of the five-man research team, "that Ancistrocladus Korupensis can be cultivated from both seeds and cuttings. The seeds do not require any particular treatment to germinate, while the cuttings only require high humidity for rooting.

"Through this study we are in our own modest way contributing to the search for a cure to the AIDS disease. Finding the cure remains a major challenge for researchers, but we think that it is possible...," Dr Mbi adds. (END/IPS/TM/PM97)


970214
IP970203


Copyright © 1997 - Inter Press Service. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Inter Press Service, IPS-ONLINE, World Desk via Panisperna 207 00184 Rome, Italy. Email: info@ips.org  http://www.ips.org

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .